Clinical Research Directory
Browse clinical research sites, groups, and studies.
Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
Sponsor: University of Alabama at Birmingham
Summary
The goal of this study is to learn whether patients who have a genetic mutation in the genes that cause alpha 1 antitrypsin deficiency also have genetic variation in nearby genes that can increase risk for reduced immune function and respiratory infections. To investigate this hypothesis, we will compare immune responses to the 20-valent pneumococcal conjugate vaccine (PCV20, Pfizer) between participants who have one abnormal copy of the SERPINA1 gene and either no COPD exacerbations, vs those with 2 or more COPD exacerbations in the past year.
Official title: Genetic Variation in IgG as a Mechanism for Immune Deficiency and Exacerbations in AATD
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-09-03
Completion Date
2027-06
Last Updated
2025-11-10
Healthy Volunteers
No
Interventions
20-valent pneumococcal conjugate vaccine
Administration of PCV20
Locations (1)
University of Alabama at Birmingham
Birmingham, Alabama, United States